Effects of Polymyxin B Immobilized Fiber on Urinary N-Acetyl-β-Glucosaminidase in Patients with Severe Sepsis
- 1 November 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Asaio Journal
- Vol. 50 (6) , 563-567
- https://doi.org/10.1097/01.mat.0000142875.62592.3a
Abstract
Severe sepsis is known to cause multiple organ failure, including renal dysfunction. During sepsis, endotoxin targets the renal proximal tubular cells, the function of which can be evaluated on the basis of urinary N-acetyl-beta-glucosaminidase (NAG). We investigated whether urinary NAG activity is altered in patients with severe sepsis and whether treatment with polymyxin B immobilized fibers (PMX-F) affects this activity. Subjects of this study were 120 patients with severe sepsis and 60 healthy volunteers matched for age and gender. Patients were randomly assigned to one of two treatments: PMX-F treatment (n = 70) or conventional treatment (n = 50). The plasma endotoxin level was significantly reduced, from 34.6 +/- 10.2 to 6.8 +/- 2.4 pg/ml (p < 0.01) in patients treated with PMX-F, and the urinary NAG/creatinine ratio was reduced from 46.5 +/- 26.8 U/gm to 18.6 +/- 13.6 U/gm (p < 0.01). The plasma endotoxin level and urinary NAG/creatinine ratio were unchanged in patients who received conventional treatment. The increased urinary NAG/creatinine ratio in patients with severe sepsis may reflect proximal tubular dysfunction. PMX-F is effective in reducing proximal tubular dysfunction, in part owing to reduced plasma endotoxin levels.Keywords
This publication has 26 references indexed in Scilit:
- Effects of pentoxifylline administration on urinary N-acetyl-β-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized studyAmerican Journal of Kidney Diseases, 2003
- Effects of Polymyxin B-Immobilized Fiber Hemoperfusion on Amino Acid Imbalance in Septic EncephalopathyBlood Purification, 2003
- Changes in Circulating Levels of Calcitonin Gene-Related Peptide and Nitric Oxide Metabolites in Septic Patients during Direct Hemoperfusion with Polymyxin B-Immobilized FiberBlood Purification, 2003
- Hemoperfusion with Polymyxin B-Immobilized Fiber in Septic Patients with Methicillin-Resistant Staphylococcus aureus-Associated GlomerulonephritisNephron Clinical Practice, 2003
- Comparison of procalcitonin and C-reactive protein as markers of sepsisCritical Care Medicine, 2003
- Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritisNephrology Dialysis Transplantation, 2002
- Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort studyIntensive Care Medicine, 2001
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001
- Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: Decrease in plasma levels of soluble P-selectin, platelet factor 4 and β-thromboglobulinInflammation Research, 1999
- Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiberIntensive Care Medicine, 1998